ahajournals.org16d
Abstract 52: Glucagon-like peptide-1 receptor agonists use and outcomes in Cardiac Amyloidosis patients: A Propensity Matched Analysis
Background: Despite their potential, Glucagon-like peptide-1 receptor agonists (GLP-1 ... and various drugs including ACEi, ARBi, ARNI, beta-blockers, and diuretics. Primary outcome was risk of ...
Medscape24d
Bridging the Care Gap in Cardiorenal Metabolic Care
Then we'll switch gears and talk about the underuse of evidence-based therapies, whether that's sodium-glucose cotransporter 2 (SGLT2) inhibitors, glucagon ... therapy: beta-blockers, an ...
HealthDay on MSN11d
Beta Blocker Might Reduce Migraine Stroke Risk
A common drug used to prevent migraines might have an additional benefit -- protecting women against stroke.Women takin ...
Nature21d
Beta-Cell Imaging and Glucagon-Like Peptide-1 Research
Recent research has highlighted the importance of glucagon-like peptide-1 (GLP-1) and its analogs in this context, as they play a significant role in beta-cell function and survival. Various ...
Too Old to Operate14d
Digoxin Offers Cost Savings Over Beta-Blockers in AF Care
The following is a summary of “Cost-effectiveness of digoxin versus beta blockers in permanent atrial fibrillation: the Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) ...
Tyler Morning Telegraph12d
Beta Blocker Might Reduce Migraine Stroke Risk
MONDAY, Feb. 3, 2025 (HealthDay News) -- A common drug used to prevent migraines might have an additional benefit -- protecting women against stroke. Women taking the beta blocker propranolol to ...